ABLYNX, INC
CONSHOHOCKEN, PA

ABLYNX, INC, CONSHOHOCKEN

Ablynx is dedicated to creating new medicines which will make a real difference to society Our Products The power of the Nanobody platform is such that Ablynx has the opportunity to generate development candidates across a range of therapeutic areas in just over two years. The breadth of the Nanobody platform and the efficiency with which leads are generated has created partnering opportunities ranging from early-stage leads to clinical-stage licensing opportunities. To learn more about drug discovery collaborations and licensing opportunities with Ablynx, please contact our [email protected] [email protected] Ablynx's Clinical Research & Development team would like to encourage potential investigators interested in collaborating with Ablynx to register their information on our website via this 

KEY FACTS ABOUT ABLYNX, INC

Company name
ABLYNX, INC
Status
Inactive
Filed Number
F18000000970
FEI Number
981153326
Date of Incorporation
February 26, 2018
Home State
DE
Company Type
Foreign for Profit

CONTACTS

Website
http://ablynx.com

ABLYNX, INC NEAR ME

Principal Address
SIX TOWER BRIDGE, SUITE 400,
181 WASHINGTON STREET,
CONSHOHOCKEN,
PA,
19428,
US

See Also

Officers and Directors

The ABLYNX, INC managed by the three persons from CONSHOHOCKEN, GHENT (ZWIJNAARDE) on following positions: MD, C/P, Director

Daniel Schneider

Position
MD Active
From
CONSHOHOCKEN, PA, 19428

Edwin Moses

Position
C/P Active
From
GHENT (ZWIJNAARDE), , 9052

Wim Ottevaere

Position
Director Active
From
GHENT (ZWIJNAARDE), , 9052





Registered Agent is C T CORPORATION SYSTEM

Address
1200 SOUTH PINE ISLAND ROAD, PLANTATION, FL, 33324

Events

May 28, 2019
WITHDRAWAL